4
Changes in Ownership
COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-22-024356
Director sold 83,964 shares at an average $23.09 ($1,939,143)
- Director acquired 83,964 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heffernan Michael Thomas Director | 2022-12-19 | Option exercise | +3,606 | $16.15 | $58,237 | 31,629 | D |
| Heffernan Michael Thomas Director | 2022-12-19 | Sale | −3,606 | $23.04 | $83,082 | 28,023 | D |
| Heffernan Michael Thomas Director | 2022-12-20 | Option exercise | +33,758 | $16.15 | $545,192 | 61,781 | D |
| Heffernan Michael Thomas Director | 2022-12-20 | Sale | −33,758 | $23.08 | $779,135 | 28,023 | D |
| Heffernan Michael Thomas Director | 2022-12-21 | Option exercise | +46,600 | $16.15 | $752,590 | 74,623 | D |
| Heffernan Michael Thomas Director | 2022-12-21 | Sale | −46,600 | $23.11 | $1,076,926 | 28,023 | D |
| Derivatives | |||||||
| Heffernan Michael Thomas Director | 2022-12-19 | Option exercise · Stock Option (Right to Purchase) | −3,606 | 105,399 | D | ||
| Heffernan Michael Thomas Director | 2022-12-20 | Option exercise · Stock Option (Right to Purchase) | −33,758 | 71,641 | D | ||
| Heffernan Michael Thomas Director | 2022-12-21 | Option exercise · Stock Option (Right to Purchase) | −46,600 | 25,041 | D | ||
| Open-market sales · 83,964 sh · avg $23.09 · $1,939,143 | |||||||
Loading xslF345X03/form4.xml…